HealthLynked Corp (HLYK) shareholders
Close on Oct 19, 2026Market cap $6.14MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of HLYK | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Ancora Advisors, LLC | 74 | 0.00% | $222 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2026 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2025 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| George O'Leary | Chief Financial Officer, Director | 4,117,896 | 139.44% | Jul 24, 2026 |
| Michael T. Dent | Chief Executive Officer, Director, 10% owner | 85,007,112 | 2878.45% | Apr 18, 2025 |
| Jeremy Daniel | Chief Financial Officer | – | – | Jan 15, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| David Rosal Chief Financial Officer | Jun 24, 2024 | Buy | +28,333 | $0.08 | $2.27K | 62,000 |
| David Rosal Chief Financial Officer | Jun 20, 2024 | Buy | +33,667 | $0.08 | $2.69K | 33,667 |
| Heather Monahan Director | Sep 27, 2023 | Award | +408,163 | – | – | 1,181,697 |
| Paul Hobaica Director | Sep 27, 2023 | Award | +408,163 | – | – | 569,107 |
| Daniel L. Hall Director | Sep 27, 2023 | Award | +408,163 | – | – | 1,181,697 |
| Robert P. Gasparini Director | Sep 27, 2023 | Award | +408,163 | – | – | 2,880,191 |
| Michael T. Dent Chief Executive Officer, Director, 10% owner | Jan 27, 2023 | Award | +50,000 | – | – | 3,010,640 |
| George O'Leary Chief Financial Officer, Director | Jan 27, 2023 | Award | +50,000 | – | – | 929,115 |
| Heather Monahan Director | Dec 8, 2022 | Award | +536,193 | – | – | 773,534 |
| Robert P. Gasparini Director | Dec 8, 2022 | Award | +536,193 | – | – | 2,472,028 |
| Daniel L. Hall Director | Dec 8, 2022 | Award | +536,193 | – | – | 773,534 |
| George O'Leary Chief Financial Officer, Director | Oct 20, 2022 | Award | +400,000 | – | – | 879,115 |
| Michael T. Dent Chief Executive Officer, Director, 10% owner | Dec 21, 2021 | Award | +2,000 | – | – | 2,960,640 |
| George O'Leary Chief Financial Officer, Director | Dec 21, 2021 | Award | +2,000 | – | – | 479,115 |
| Robert P. Mino Director | Nov 22, 2021 | Award | +74,766 | – | – | 638,604 |
| Heather Monahan Director | Nov 22, 2021 | Award | +74,766 | – | – | 237,341 |
| Robert P. Gasparini Director | Nov 22, 2021 | Award | +74,766 | – | – | 1,935,835 |
| Daniel L. Hall Director | Nov 22, 2021 | Award | +74,766 | – | – | 237,341 |
| Heather Monahan Director | Nov 12, 2021 | Award | +68,942 | – | – | 231,517 |
| Daniel L. Hall Director | Nov 12, 2021 | Award | +68,942 | – | – | 231,517 |
| Robert P. Gasparini Director | Nov 12, 2021 | Award | +68,942 | – | – | 1,930,011 |
| Robert P. Mino Director | Nov 12, 2021 | Award | +68,942 | – | – | 632,780 |
| Robert P. Gasparini Director | Jul 21, 2021 | Option exercise | +312,250 | $0.10 | $31.23K | 1,779,532 |
| Robert P. Gasparini Director | Apr 30, 2021 | Award | +354,234 | – | – | 1,467,282 |
| Heather Monahan Director | Apr 30, 2021 | Award | +81,288 | – | – | 81,288 |
| Robert P. Mino Director | Apr 30, 2021 | Award | +289,694 | – | – | 482,551 |
| Robert P. Mino Director | Mar 2, 2021 | Buy | +50,000 | $0.50 | $25.00K | 192,857 |
| George O'Leary Chief Financial Officer, Director | Mar 1, 2021 | Buy | +50,000 | $0.50 | $25.00K | 3,757,328 |
| Michael T. Dent Chief Executive Officer, Director, 10% owner | Jan 13, 2021 | Award | +5,000 | – | – | 84,955,112 |
| George O'Leary Chief Financial Officer, Director | Jan 13, 2021 | Award | +5,000 | – | – | 3,535,213 |
| George O'Leary Chief Financial Officer, Director | Jan 13, 2021 | Buy | +100,000 | – | – | 3,635,213 |
| Daniel L. Hall Director | Nov 9, 2020 | Award | +162,575 | – | – | 162,575 |
| Michael T. Dent Chief Executive Officer, Director, 10% owner | Oct 19, 2020 | Other | +10,573,745 | $0.14 | $1.48M | 84,950,112 |
| George O'Leary Chief Financial Officer, Director | Oct 19, 2020 | Other | +1,130,213 | $0.14 | $158.23K | 3,530,213 |
| Robert P. Gasparini Director | Oct 19, 2020 | Other | +99,437 | $0.14 | $13.92K | 1,113,048 |
| Michael T. Dent Chief Executive Officer, Director | Aug 24, 2020 | Other | +24,522,727 | $0.12 | $2.94M | 74,376,367 |
| George O'Leary Chief Financial Officer, Director | Jul 20, 2020 | Award | +100,000 | – | – | 2,400,000 |
| Robert P. Mino Director | Jan 3, 2020 | Award | +142,857 | $0.14 | $20.00K | 142,857 |
| George O'Leary Chief Financial Officer, Director | Jul 1, 2018 | Award | +100,000 | – | – | 2,200,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Sep 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of HealthLynked's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?